Mi1250 SYNCHRONY 2 FLEXsoft
Device Cochlear Implant
PDI 09008737366780
General payments
$3,811,671
Research payments
$3,688,719
Through program year 2025, $3,811,671 in general payments and $3,688,719 in research payments were reported against Mi1250 SYNCHRONY 2 FLEXsoft (Cochlear Implant).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,439,569 | 947 |
| 2025 | Research | $522,411 | 31 |
| 2024 | General | $1,017,450 | 1,085 |
| 2024 | Research | $774,114 | 34 |
| 2023 | General | $496,926 | 682 |
| 2023 | Research | $961,653 | 46 |
| 2022 | General | $771,441 | 550 |
| 2022 | Research | $1,430,540 | 51 |
| 2021 | General | $86,285 | 9 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,273 general · 162 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.